| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 172476-17-4 | Amopyroquine N-Oxide | 無 | 詳情 | 供應(yīng)商 | ||
| 85320-68-9 | 氨磺洛爾 | Amosulalol; Amosulalol; Benzenesulfonamide, 5-[1-hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methyl-; Benzenesulfonamide, 5-[1-hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methyl-, (+-)- |  | C18H24N2O5S | 詳情 | 供應(yīng)商 |
| 70958-86-0 | YM 09538; Benzenesulfonamide, 5-[1-hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methyl-, monohydrochloride; Lowgan; YM 09538; AMOSULALOLHYOROCHLORIDE |  | 詳情 | 供應(yīng)商 | ||
| 94659-47-9 | Amoxicillin Diketopiperazine (Mixture of Diastereomers) | 無 | 詳情 | 供應(yīng)商 | ||
| 117147-70-3 | AMPHIREGULIN HUMAN RECOMBINANT; AMPHIREGULIN HUMAN RECOMBINANT; Amphinegulin; Keratinocyte autocrine factor | 無 | 詳情 | 供應(yīng)商 | ||
| 75898-90-7 | 3-hydroxypropanoic acid; 3-amino-5-pyridin-4-yl-1H-pyridin-2-one; (3,4'-Bipyridin)-6(1H)-one, 5-amino-, 3-hydroxypropanoate; 3-Hydroxypropanoic acid compd. with 5-amino-(3,4'-bipyridin)-6(1H)-one; Amrinone lactate; Inamrinone lactate; Propanoic acid, 3-hydroxy-, compd. with 5-amino-(3,4'-bipyridin)-6(1H)-one; Unii-I229274Y5b |  | C13H15N3O4 | 詳情 | 供應(yīng)商 | |
| 110267-81-7 | 氨柔比星 | AMRUBICIN; (7S,9S)-9-Acetyl-9-amino-7-[(2-deoxy--D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione; (7S)-9β-Amino-9-acetyl-7β-[(2-deoxy-β-D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxynaphthacene-5,12-dione; (7S,9S)-9-Acetyl-9-amino-7-(2-deoxy-β-D-erythro-pentopyranosyloxy)-6,11-dihydroxy-5,7,8,9,10,12-hexahydro-5,12-naphthacenedione; (7S,9S)-9-Amino-9-acetyl-7-[(2-deoxy-β-D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxynaphthacene-5,12-dione; Amurubicin |  | C25H25NO9 | 詳情 | 供應(yīng)商 |
| 186353-53-7 | amrubicinol; amrubicinol; (7S,9S)-9-Amino-7-[(2-deoxy--D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-9-(1-hydroxyethyl)-5,12-naphthacenedione; 13-Hydroxy SM 5887; Amrubicinol (Mixture of Diastereomers) |  | C25H27NO9 | 詳情 | 供應(yīng)商 | |
| 672-72-0 | 無 | 詳情 | 供應(yīng)商 | |||
| 118068-30-7 | SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER | H-SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER-OH; H-SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER-OH; AMYLIN FRAGMENT 20-29 HUMAN; AMYLIN (20-29); AMYLIN (20-29) (HUMAN); SNNFGAILSS; SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER; diabetes associated peptide fragment 20-29 human |  | C43H68N12O16 | 詳情 | 供應(yīng)商 |
| 122384-88-7 | 糖尿病相關(guān)肽(胰島淀粉樣肽)(抗原) | AMYLIN, HUMAN; KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 (DISULFIDE BRIDGE: 2-7); LYS-CYS-ASN-THR-ALA-THR-CYS-ALA-THR-GLN-ARG-LEU-ALA-ASN-PHE-LEU-VAL-HIS-SER-SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER-THR-ASN-VAL-GLY-SER-ASN-THR-TYR-NH2; DIABETES ASSOCIATED PEPTIDE AMIDE HUMAN; DIABETES-ASSOCIATED PEPTIDE (DAP) AMIDE, HUMAN; DIABETES-ASSOCIATED PEPTIDE HUMAN; DAP (HUMAN); DAP AMIDE, HUMAN; DAP |  | C8H17O3 * | 詳情 | 供應(yīng)商 |
| 131438-74-9 | AMYLOID BETA-PROTEIN (1-38); AMYLOID BETA-PROTEIN (1-38); AMYLOID BETA-PROTEIN FRAGMENT 1-38; DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGG; H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-OH; BETA-AMYLOID (1-38); amyloid B-protein fragment 1-38; amyloid β protein fragment 1-38 | 無 | C184H277N51O56S1 | 詳情 | 供應(yīng)商 | |
| 131438-79-4 | BETA淀粉樣蛋白片段1-40 | AMYLOID BETA-PROTEIN (HUMAN, 1-40) TRIFLUOROACETATE; AMYLOID B-PROTEIN FRAGMENT 1-40; Amyloidb-Peptide(1-40)(human); H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Gly-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH; amyloid β protein fragment 1-40; aβ40; SS-AMYLOID (1-40), RAT; M.W. 4329.86 C194H295N53O58S; beta Amyloid (1-40) human | 無 | C194H295N53O58S1 | 詳情 | 供應(yīng)商 |
| 107761-42-2 |  | 詳情 | 供應(yīng)商 | |||
| 152286-31-2 | TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE | H-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-OH; AMYLOID BETA-PROTEIN (10-20); AMYLOID BETA-PEPTIDE (10-20) (HUMAN); AMYLOID BETA-PROTEIN FRAGMENT 10-20; H-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-OH; BETA-AMYLOID (10-20); YEVHHQKLVFF; TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE; amyloid B-protein fragment 10-20 |  | C71H99N17O16 | 詳情 | 供應(yīng)商 |
| 107015-83-8 | 淀粉-Β-蛋白片段12-28 | H-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-OH; H-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-OH; BETA-AMYLOID (12-28); BETA-AMYLOID PEPTIDE [12-28], HUMAN; ALZHEIMER'S DISEASE BETA-PROTEIN (12-28); AMYLOID, BETA- (12-28), HUMAN; AMYLOID BETA-PROTEIN (12-28); AMYLOID-BETA PROTEIN (12-28), HUMAN; AMYLOID BETA-PROTEIN FRAGMENT 12-28 |  | C89H135N25O25 | 詳情 | 供應(yīng)商 |
| 134500-80-4 | 淀粉Β-蛋白(1-43) | BETA-AMYLOID (1-43); BETA-AMYLOID (1-43); BETA-AMYLOID (1-43) PEPTIDE; BETA-AMYLOID PEPTIDE [1-43], HUMAN; DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIAT; H2N-D-A-E-F-R-H-D-S-G-Y-E-V-H-H-Q-K-L-V-F-F-A-E-D-V-G-S-N-K-G-A-I-I-G-L-M-V-G-G-V-V-I-A-T-OH; H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA-THR-OH; A-BETA (1-43); AMYLOID BETA-PROTEIN (1-43) | 無 | C207H318N56O62S1 | 詳情 | 供應(yīng)商 |
| 317366-82-8 | 淀粉Β-蛋白(42-1) | AMYLOID BETA-PROTEIN (42-1) TRIFLUOROACETATE; ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA TRIFLUOROACETATE; ALA-ILE VAL-VAL-GLY-GLY-VAL-MET-LEU-GLY-ILE-ILE-ALA-GLY-LYS-ASN-SER-GLY-VAL-ASP-GLU-ALA-PHE-PHE-VAL-LEU-LYS-GLN-HIS-HIS-VAL-GLU-TYR-GLY-SER-ASP-HIS-ARG-PHE-GLU-ALA-ASP TRIFLUOROACETATE; AMYLOID BETA-PROTEIN (42-1) TRIFLUOROACETATE; AMYLOID BETA-PROTEIN (HUMAN, 1-42) TRIFLUOROACETATE; PEPTIDE WITH REVERSED SEQUENCE OF AMYLOID BETA-PROTEIN (HUMAN, 1-42) TRIFLUOROACETATE; Amyloid β-Protein (42-1); b-Amyloid (42-1); Amyloid β-peptide (42-1) (human) | 無 | C203H311N55O60S | 詳情 | 供應(yīng)商 |
| 144409-98-3 | AMYLOID BETA-PROTEIN (1-40) (MOUSE, RAT); Amyloid β-peptide (1-40) (rat) | 無 | C190H291N51O57S | 詳情 | 供應(yīng)商 | |
| 166090-74-0 | H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH | H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GL; PREDOMINANT AMYLOID B-PROTEIN FRAGMENT; ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA; ASP-ALA-GLU-PHE-GLY-HIS-ASP-SER-GLY-PHE-GLU-VAL-ARG-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA; BAP 1-42; BETA-AMYLOID, SODIUM SALT; BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT; BETA-AMYLOID PEPTIDE (1-40), RAT; BETA-AMYLOID PEPTIDE (1-42), RAT | 無 | C203H311N55O60S | 詳情 | 供應(yīng)商 |